Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells

doi:10.3748/wjg.v24.i21.2236

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9588)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

722

WORD

355

HTML

5454

Figures (1-1)

278

Tables (1-3)

329

Sum=7138

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1021

Download

1429

Sum=2450

Jun 7, 2018 (publication date) through Dec 30, 2024

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 7, 2018; 24(21): 2236-2246
Published online Jun 7, 2018. doi: 10.3748/wjg.v24.i21.2236

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow chart of current and potential applications of circulating tumor cell. Circulating tumor cells (CTCs): The blood samples from cancer patients are processed through various isolation/enrichment and detection techniques. CTCs are usually captured along with contaminating leukocytes. Various detection methods are utilized to detect the rare cell population in the bloodstream.

Citation: Li TT, Liu H, Yu J, Shi GY, Zhao LY, Li GX. Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells. World J Gastroenterol 2018; 24(21): 2236-2246
URL: https://www.wjgnet.com/1007-9327/full/v24/i21/2236.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i21.2236